World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
29496
World Ranking
13129
National Ranking
146

Overview

Yok-Lam Kwong is affiliated with the University of Hong Kong in China and has a research focus primarily in the field of Medicine, with a specialization in Hematology. Their scholarly contributions cover a range of subfields including Hematology, Pathology and Forensic Medicine, Oncology, Genetics, and Molecular Biology.

The scientist's research topics include:

  • Lymphoma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Viral-associated cancers and disorders
  • Retinoids in leukemia and cellular processes
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Chronic Myeloid Leukemia Treatments

Yok-Lam Kwong has contributed to numerous papers, including the following notable recent publications:

  • "Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma," 2021, New England Journal of Medicine
  • "How we treat NK/T-cell lymphomas," 2022, Journal of Hematology & Oncology
  • "Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy," 2022, Journal of Clinical Oncology
  • "Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma," 2020, Leukemia
  • "Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study," 2021, Journal of Hematology & Oncology

Throughout their career, Yok-Lam Kwong has frequently published in various academic venues, with the highest number of publications appearing in:

  • Annals of Hematology
  • Blood
  • Frontiers in Oncology
  • Hematology
  • HemaSphere

The scientist has collaborated extensively with several co-authors, among them:

  • Eric Tse
  • Harinder Gill
  • Rita Yim
  • Paul Lee
  • Joycelyn Sim

Best Publications

  • Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation

    Hung-Fat Tse;Yok-Lam Kwong;John K F Chan;Gladys Lo

  • Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.

    Anupama Reddy;Jenny Zhang;Nicholas S. Davis;Andrea B. Moffitt

  • Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

    Motoko Yamaguchi;Yok Lam Kwong;Won Seog Kim;Yoshinobu Maeda

  • The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9.

    Julian Borrow;Amanda M. Shearman;Vincent P. Stanton;Reinhard Becher

  • Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.

    Chee–Kin Hui;Winnie W.W. Cheung;Hai–Ying Zhang;Wing–Yan Au

  • Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index

    Chor-Sang Chim;Shing-Yan Ma;Wing-Yan Au;Carolyn Choy

  • PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase

    Yok-Lam Kwong;Thomas S. Y. Chan;Daryl Tan;Seok Jin Kim

  • SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group

    Yok-Lam Kwong;Won Seog Kim;Soon Thye Lim;Seok Jin Kim

  • Sorafenib treatment of FLT3-ITD(+) acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation.

    Cheuk Him Man;Tsz Kan Fung;Christa Ho;Heron H C Han

  • Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer

    A. O.-O. Chan;S.-K. Lam;B. C.-Y. Wong;W.-M. Wong

  • Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients.

    Wing-Yan Au;Annie Pang;Carolyn Choy;Chor-Sang Chim

  • How I treat NK/T-cell lymphomas

    Eric Tse;Yok-Lam Kwong

  • A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

    Seok Jin Kim;Dok Hyun Yoon;Arnaud Jaccard;Wee Joo Chng

  • SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway

    Chor-Sang Chim;Tsz-Kin Fung;Wai-Chung Cheung;Raymond Liang

  • CD56+ NK lymphomas: Clinicopathological features and prognosis

    Y. L. Kwong;A. C. L. Chan;R. Liang;A. K. S. Chiang

  • Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia

    Philipp Le Coutre;Oliver G. Ottmann;Francis Giles;Dong Wook Kim

  • Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study

    Wai-Kay Seto;Thomas S.Y. Chan;Yu-Yan Hwang;Danny Ka-Ho Wong

  • Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation.

    Anskar Y. H. Leung;Christine K. M. Suen;Albert K. W. Lie;Raymond H. S. Liang

  • The diagnosis and management of NK/T-cell lymphomas

    Eric Tse;Yok-Lam Kwong

  • Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years

    W.-Y. Au;S.-Y. Ma;C.-S. Chim;C. Choy

Frequent Co-Authors

Hung-Fat Tse
Hung-Fat Tse University of Hong Kong
Chu-Pak Lau
Chu-Pak Lau University of Hong Kong
John K.C. Chan
John K.C. Chan Tuen Mun Hospital
George K. K. Lau
George K. K. Lau Humanity & Health
Kwok-Yung Yuen
Kwok-Yung Yuen University of Hong Kong
Ritsuro Suzuki
Ritsuro Suzuki Shimane University
Irene Oi-Lin Ng
Irene Oi-Lin Ng University of Hong Kong
Ching-Lung Lai
Ching-Lung Lai University of Hong Kong
Man-Fung Yuen
Man-Fung Yuen University of Hong Kong
Vincent C. C. Cheng
Vincent C. C. Cheng University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine or healthcare, there are a range of related online programs designed to help you achieve your goals. Flexible online options make advanced education more accessible, allowing you to balance study with existing commitments.

For nurses wishing to take on advanced clinical roles, adn to np programs online offer a streamlined route from associate to nurse practitioner, opening doors in primary and specialized care. Those interested in combining food science and wellness can pursue an online nutrition degree, which can lead to roles in dietetics, public health, or the food industry.

Aspiring healthcare administrators may choose from top cahme accredited mha programs, focusing on management, policy, and organizational leadership within healthcare systems. Current registered nurses looking to advance their education without the need for onsite experience can explore online rn to bsn programs without clinicals for greater career mobility and higher earning potential.

No matter your area of interest, these accredited online pathways provide the skills and credentials needed to excel in today’s healthcare landscape.

Best Scientists Citing Yok-Lam Kwong

Trending Scientists